OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNIOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS
The present invention provides a kit for the dietary management of cardiovascular patients with cardiovascular disease who are deficient in blood Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) levels, said kit including a diagnostic assay for determining blood levels of EPA, DHA and Docosapentaenoic acid (DPA) and a pharmaceutical grade prescription medical food omega-3 fatty acid formulation containing about 90% or more omega 3 fatty acids by weight including a combination of EPA, DPA and DHA in a weight ratio of EPA: DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA are about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition. EPA + DHA are about 80% of the total formulation and about 89% of the total omega 3 fatty acid content of the composition. The formulation may further contain specific amounts of arachidonic acid (AA) and of omega-3 fatty acids having 18 carbon atoms, including one or more of stearidonic acid (SDA) and alpha-linolenic acid (ALA). The kit may further contain instructions for use of its components.La présente invention concerne un kit pour la gestion du régime alimentaire de patients atteints de maladies cardiovasculaires présentant une déficience en termes de niveaux dacide eicosapentaénoïque (EPA) et dacide docosahexaénoïque (DHA) dans le sang, ledit kit comprenant un dosage diagnostique qui permet de déterminer les niveaux dans le sang dEPA, de DHA et dacide docosapentaénoïque (DPA) et une formulation dacides gras oméga-3 à utiliser en tant qualiment thérapeutique de qualité pharmaceutique à délivrer sous ordonnance, contenant environ 90 % en poids ou plus dacides gras oméga-3 comprenant une combinaison dEPA, de DPA et de DHA selon un rapport de poids EPA: DHA compris entre 5,7 et 6,3 la somme dEPA, de DHA et de DPA représentant environ 82 % en poids de la formulation totale et environ 92 % de la teneur totale en acides gras oméga-3 de la composition. LE
